179 related articles for article (PubMed ID: 36572949)
1. Increased expression of ECT2 predicts the poor prognosis of breast cancer patients.
Yi M; Zhang D; Song B; Zhao B; Niu M; Wu Y; Dai Z; Wu K
Exp Hematol Oncol; 2022 Dec; 11(1):107. PubMed ID: 36572949
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer.
Xiu Y; Liu W; Wang T; Liu Y; Ha M
Mol Clin Oncol; 2019 May; 10(5):497-505. PubMed ID: 30967944
[TBL] [Abstract][Full Text] [Related]
3. Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA.
Bai X; Yi M; Xia X; Yu S; Zheng X; Wu K
Cancer Manag Res; 2018; 10():4039-4050. PubMed ID: 30319288
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis.
Li Y; Cai X; Chen B; Gu H; Liu C
Exp Ther Med; 2017 Nov; 14(5):4862-4868. PubMed ID: 29109759
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer.
Luo Y; Qin SL; Mu YF; Wang ZS; Zhong M; Bian ZQ
Biomed Pharmacother; 2015 Jul; 73():135-9. PubMed ID: 26211594
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.
Guo Z; Chen X; Du T; Zhu D; Lai Y; Dong W; Wu W; Lin C; Liu L; Huang H
Med Oncol; 2017 Jan; 34(1):13. PubMed ID: 28012134
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic significance of ECT2 in invasive breast cancer.
Wang HK; Liang JF; Zheng HX; Xiao H
J Clin Pathol; 2018 May; 71(5):442-445. PubMed ID: 29051317
[TBL] [Abstract][Full Text] [Related]
8. ECT2 Increases the stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer.
Wang J; Yang S; Min L; Zhu S; Guo S; Zhang S
Front Oncol; 2020; 10():589241. PubMed ID: 33634019
[TBL] [Abstract][Full Text] [Related]
9. The Oncogene ECT2 Contributes to a Hyperplastic, Proliferative Lung Epithelial Cell Phenotype in Idiopathic Pulmonary Fibrosis.
Ulke HM; Mutze K; Lehmann M; Wagner DE; Heinzelmann K; Günther A; Eickelberg O; Königshoff M
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):713-726. PubMed ID: 31145635
[TBL] [Abstract][Full Text] [Related]
10. Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation.
Saito S; Liu XF; Kamijo K; Raziuddin R; Tatsumoto T; Okamoto I; Chen X; Lee CC; Lorenzi MV; Ohara N; Miki T
J Biol Chem; 2004 Feb; 279(8):7169-79. PubMed ID: 14645260
[TBL] [Abstract][Full Text] [Related]
11. The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.
Mansour M; Haupt S; Chan AL; Godde N; Rizzitelli A; Loi S; Caramia F; Deb S; Takano EA; Bishton M; Johnstone C; Monahan B; Levav-Cohen Y; Jiang YH; Yap AS; Fox S; Bernard O; Anderson R; Haupt Y
Cancer Res; 2016 Jul; 76(14):4236-48. PubMed ID: 27231202
[TBL] [Abstract][Full Text] [Related]
12. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
[TBL] [Abstract][Full Text] [Related]
13. The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition.
Scoumanne A; Chen X
Cancer Res; 2006 Jun; 66(12):6271-9. PubMed ID: 16778203
[TBL] [Abstract][Full Text] [Related]
14. Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis.
Li C; Peng Z; Wang Y; Lam G; Nissen N; Tang J; Yuan X; Lewis M; Greene MI; Pandol SJ; Wang Q
Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G380-G395. PubMed ID: 33501895
[TBL] [Abstract][Full Text] [Related]
15. A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.
Zhang Q; Cao C; Gong W; Bao K; Wang Q; Wang Y; Bi L; Ma S; Zhao J; Liu L; Tian S; Zhang K; Yang J; Yao Z; Song N; Shi L
Theranostics; 2020; 10(23):10769-10790. PubMed ID: 32929379
[No Abstract] [Full Text] [Related]
16. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma.
Zhu L; Qin G; Ye L; Jiang LZ; Zhou TJ; Luo B; Wen TY; Liu YL; Chen HY
Oncol Lett; 2019 Jun; 17(6):5699-5704. PubMed ID: 31186795
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of ECT2 is associated with transcriptional program of cancer stem cells and predicts poor clinical outcome in gastric cancer.
Gong DY; Chen X; Yang TL; Wang Y; Guo Y; Zeng JH; Chen SZ
Oncol Lett; 2020 Oct; 20(4):54. PubMed ID: 32788941
[TBL] [Abstract][Full Text] [Related]
19. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients.
Sano M; Genkai N; Yajima N; Tsuchiya N; Homma J; Tanaka R; Miki T; Yamanaka R
Oncol Rep; 2006 Nov; 16(5):1093-8. PubMed ID: 17016598
[TBL] [Abstract][Full Text] [Related]
20. Expression of a Rho guanine nucleotide exchange factor, Ect2, in the developing mouse pituitary.
Islam MS; Tsuji T; Higashida C; Takahashi M; Higashida H; Koizumi K
J Neuroendocrinol; 2010 May; 22(5):477-82. PubMed ID: 20141573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
